Hostname: page-component-848d4c4894-xfwgj Total loading time: 0 Render date: 2024-06-14T22:47:01.810Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of Longitudinal Surveillance Data to Assess the Effectiveness of Infection Control in Critical Care

Published online by Cambridge University Press:  02 January 2015

John W. Ahern  and
W. Kemper Alston
John W. Ahern
Affiliation:
Department of Pharmacy and the Infectious Diseases Unit, Fletcher Allen Health Care, and the College of Medicine, University of Vermont, Burlington
W. Kemper Alston*
Affiliation:
Department of Pharmacy and the Infectious Diseases Unit, Fletcher Allen Health Care, and the College of Medicine, University of Vermont, Burlington
*
Infectious Diseases Unit, Smith 287, Medical Center Hospital of Vermont Campus, Fletcher Allen Health Care, 111 Colchester Ave, Burlington, VT 05401 (wallace.alston@vtmednet.org)
Get access Rights & Permissions [Opens in a new window]

Abstract

A simple method for quantifying nosocomial infection and colonization with multidrug-resistant organisms is described. This method is applied to the intensive care unit of an academic medical center where longitudinal surveillance data have been used to assess the impact of infection control interventions and antibiotic use.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 30 , Issue 11 , November 2009 , pp. 1109 - 1112
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Shlaes, DM, Gerding, DN, John, JF Jret al.Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997;18:275–291.CrossRefGoogle Scholar
2.Kollef, MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000;31(Suppl 4):S131–S138.Google Scholar
3.Siegel, JD, Rhinehart, E, Jackson, M, et al.Management of multidrug-resistant organisms in healthcare settings, 2006. Am J Infect Control 2007;35:S165–S193.Google Scholar
4.Goldmann, DA, Weinstein, RA, Wenzel, RP, et al.Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996;275:234–240.Google Scholar
5.Kollef, M, Fraser, VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001;134:298–313.Google Scholar
6. WHO Collaborating Centre for Drug Statistics Methodology. About the ATC/DDD system. Available at: http://www.whocc.no/atcddd/. Accessed January 28, 2009.Google Scholar
7.Burton, DC, Edwards, JR, Horan, TC, et al.Methicillin-resistant Staphylococcus aureus central line–associated bloodstream infections in US intensive care units, 1997–2007. JAMA 2009;301:727–736.CrossRefGoogle ScholarPubMed
8.Mandell, LA, Wunderink, RG, Anzueto, A, et al.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27–S72.CrossRefGoogle Scholar
9.American Thoracic Society and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388–416.Google Scholar